变态另类zoz0另类,在线精品亚洲一区二区,无码精品黑人一区二区三区,四虎影视无码永久免费无码

Recently, Prince Mong Ratchawong Jirakong Kitti Yaguan, Chairman of the Belt and Road International Cooperation Organization of Thailand, Dr. Dan, the Prince's Assistant, Han Wenhua, Chairman of the Thai-Chinese Friendship Association, Lin Xiaoqin, wife of Chairman Han Wenhua, Kaiwen Susongji, Vice Chairman of the Thai-Chinese Friendship Association, Dang Hongying, Vice Chairman of the Belt and Road International Cooperation Organization, and Meng Fanjian, Assistant to the Vice Chairman of the Belt and Road International Cooperation Organization, visited Bio-S Pharmaceutical for inspection and exchanges. They were accompanied by Li Kangyue, Chairman of Duanben Pharmaceutical, Lou Jinfang, Chairman and General Manager of Bio-S Pharmaceutical, and relevant personnel.

d'hAt Bio-S Pharmaceutical Linping Park, President Lou accompanied the prince and his party to visit the company's exhibition hall and introduced the company's development model, core technology platform and future industrial layout.

At the symposium, President Lou warmly welcomed the delegation led by Prince Mong Rachawong Jirakorn Kitti Yaguan and introduced the company's future international development path. She said that as an important participant in the "Belt and Road Initiative", Thailand has increasingly close economic, trade, scientific and cultural cooperation with China. In the field of medicine, the cooperation between the two sides has broad prospects and huge development potential. Bio-S Pharmaceutical and Duanben Pharmaceutical will continue to expand the Southeast Asian market and explore more diversified and in-depth cooperation.

Mr. Lou emphasized that Bio-S Pharmaceutical always pays attention to the efficacy, safety and stability of drugs in the process of new drug research and development. The company will strictly carry out new drug research and development in accordance with international standards and specifications to ensure the quality and safety of new drugs. At the same time, Bio-S Pharmaceutical will also actively introduce internationally advanced research and development technologies and products to continuously improve its own research and development level and innovation capabilities.

Li Kangyue, Chairman of Duanben Pharmaceutical, said in his speech that Duanben Pharmaceutical will make full use of its profound background and unique advantages in new drug certification and promotion, and go all out to promote innovative drugs to a wider market. At the same time, through close cooperation with countries along the "Belt and Road" such as Thailand, Duanben Pharmaceutical can not only introduce new drugs to these markets with huge potential, providing patients with more treatment options and hope, but also leverage the medical resources and R&D advantages of these countries to further enhance our new drug R&D strength and innovation capabilities. In the future, Duanben Pharmaceutical will continue to uphold the concept of openness, cooperation, and win-win, and work hand in hand with more domestic and foreign partners to jointly promote the prosperity and development of the global new drug research and development field.

After listening to the company's future international development strategy, Prince Mong Ratchavong Jirakong Kitti Yaguan said that Thai medicine has a long history and has unique advantages in treating liver and kidney diseases, diabetes, hypertension, etc., which fully demonstrates the profound heritage of Thai medicine culture and its unique value in the treatment of specific diseases. Thai people's love for tradition has made local Thai medicine and Chinese medicine occupy an important position in the Thai market, and the characteristics of Thai medicine that are harmless to the liver and kidneys have won it a good reputation in the international market. He looks forward to the future of Bio-S Pharmaceutical and Duanben Pharmaceutical to work hand in hand with local Thai companies to jointly explore cooperation opportunities in the fields of new drug research and development, market promotion, etc., to bring more health and well-being to the people of the two countries.

Later, Li Dawei, deputy dean of Linping Research Institute of Zhejiang University, introduced the establishment background and future development plan of Zhejiang University’s “Belt and Road” International Medical College. "Since its establishment, we have been committed to building an international medical education and research platform, aiming to promote in-depth cooperation and exchanges in the medical field between China and countries along the 'Belt and Road'." Li Dawei said that in terms of international enrollment, the college Remarkable results have been achieved, especially with Thai students accounting for the highest proportion of enrollment. This not only reflects the influence of Zhejiang University in Thailand and even Southeast Asia, but also reflects the unique advantages of the college in the internationalization process. In addition, Li Dawei also revealed that the college will set up relevant courses in the direction of industrial cooperation to cultivate technical talents in the industry and promote international pharmaceutical cooperation.

Dr. Jiang Xue, head of Bio-S Pharmaceutical's overseas business, introduced the achievements of Bio-S Pharmaceutical in expanding overseas markets. When talking about the future direction of cooperation, Dr. Jiang Xue mentioned that Bio-S Pharmaceutical looks forward to more in-depth cooperation and exchanges with all parties in going overseas. Especially in the export of APIs and preparations, the company will continue to strengthen communication and collaboration with international customers and jointly explore new cooperation models and business areas. At the same time, the company also hopes to establish closer ties with partners in technology transfer, technology research and development, and the application of innovative drugs in Thailand, so as to jointly promote the innovation and development of the pharmaceutical industry.

In a warm and friendly atmosphere, Han Wenhua, Chairman of the Thai-Chinese Friendship Association, Li Kangyue, Chairman of Duanben Pharmaceutical, and Lou Jinfang, Chairman and General Manager of Bio-S Pharmaceutical, signed a cooperation agreement on the spot as representatives of the three parties, formally establishing a strategic cooperative relationship.